SCHEMBL9328704

SCHEMBL9328704

CCCC(=O)Nc1nc(C(=O)NCCO[N+](=O)[O-])cs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
ALDH1A1 P00352 3/20 0.47
GAA P10253 5/20 0.46
RAB9A P51151 7/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
NPC1 O15118 4/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ACHE P22303 1/20 0.39
RAD52 P43351 1/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9329454 0.92 PDE5A (0.49) CYP2C19CYP1A2ALDH1A1GAALMNA
SCHEMBL9329949 0.87 L3MBTL1 (0.50) CYP2C19CYP1A2ALDH1A1GAARAB9A
SCHEMBL9329414 0.86 CYP2C19 (0.43) CYP2C19CYP1A2ALDH1A1GAARAB9A
SCHEMBL9331832 0.85 CYP2C19 (0.42) CYP2C19CYP1A2ALDH1A1GAARAB9A
SCHEMBL9329282 0.85 CYP2C19 (0.45) CYP2C19CYP1A2ALDH1A1GAARAB9A
SCHEMBL9329984 0.81 RAB9A (0.55) CYP2C19CYP1A2ALDH1A1RAB9ASMN1; SMN2
SCHEMBL9328726 0.80 HIF1A (0.54) CYP2C19ALDH1A1RAB9ASMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL9329264 0.79 HIF1A (0.53) CYP2C19ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL9329461 0.78 MEN1 (0.48) CYP2C19CYP1A2ALDH1A1GAARAB9A
Hydrochloric Acid SCHEMBL9331249 0.78 CYP2C9 (0.41) CYP2C19CYP1A2GAARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0300400-B1 Nitric acid ester derivative FUJISAWA PHARMACEUTICAL CO (JP) 1994-03-16 EP disclosed
US-5010093-A Vasodilators; cardiovascular disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-04-23 US disclosed
US-4923886-A VASODILATORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-08 US disclosed
EP-0300400-A1 Nitric acid ester derivative FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-25 EP disclosed